🔎 Trials Near Me

Hjem › Overvægt › Florida › Orlando

Overvægt kliniske forsøg i Orlando, FL

27 studier for Overvægt søger deltagere på steder i og omkring Orlando (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

RekruttererFase 2
  • Charter Research - Winter Park /ID# 281968, Orlando
  • Florida Institute For Clinical Research /ID# 282739, Orlando
Alder 18 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07752979

Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients

Rekrutterer
  • Orlando Health, Inc., Orlando
Alder 21 til 65 · Alle køn · Opdateret 1. okt. 2026 · NCT07090005

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

RekruttererFase 1Frivillige med god helbredstilstand velkomne
  • Kailera Clinical Site, Orlando
Alder 18 til 85 · Alle køn · Opdateret 1. okt. 2026 · NCT07793929

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

RekruttererFase 3
  • Florida Institute for Clinical Research, LLC, Orlando
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07533175

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

RekruttererFase 2
  • Clinical Site Partners, LLC DBA Flourish Research, Winter Park · 5 mi væk
  • K2 Medical Research Maitland LLC, Main Office, Maitland · 6 mi væk
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07685808

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

RekruttererFase 2
  • Clinical Neuroscience Solutions, Orlando
Alder 18 til 75 · Alle køn · Opdateret 28. sep. 2026 · NCT07837973

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

RekruttererFase 3
  • Clinical Neuroscience Solution, Orlando
  • Florida Institute for Clinical Research, LLC, Orlando
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

RekruttererFase 3
  • Florida Inst For Clin Res LLC, Orlando
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

RekruttererFase 3
  • Headlands Research Orlando, Orlando
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07794579

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

RekruttererFase 3
  • Orlando Health, Orlando
  • Digestive and Liver Center of Florida, Orlando
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

RekruttererFase 3
  • Florida Hospital- Center for Pediatric Research, Orlando
  • Nemours Children's Health, Orlando
Alder 6 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

RekruttererFase 3
  • Orlando Health, Orlando
  • Digestive and Liver Center of Florida, Orlando
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

RekruttererFase 3
  • Clinical Site Partners, LLC dba Flourish Research, Winter Park · 5 mi væk
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

RekruttererFase 3
  • Research Site, Ocoee · 10 mi væk
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

RekruttererFase 3
  • West Orange Endocrinology, Ocoee · 10 mi væk
Alder 45 til 99 · Alle køn · Opdateret 22. sep. 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

RekruttererFase 3
  • Conquest Research, Winter Park · 5 mi væk
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

RekruttererFase 2
  • Charter Research - Winter Park, Orlando
Alder 18 til 75 · Alle køn · Opdateret 22. sep. 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

RekruttererFase 3
  • AURORA-1 Clinical Site, Winter Park · 5 mi væk
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

RekruttererFase 3
  • AURORA-2 Clinical Site, Winter Park · 5 mi væk
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07743450

Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households

Rekrutterer
  • University of Central Florida, Orlando
Alder 5 til 11 · Alle køn · Opdateret 14. sep. 2026 · NCT07464015

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

RekruttererFase 3Frivillige med god helbredstilstand velkomne
  • ACCOMPLISH-2 Research Site, Ocoee · 10 mi væk
Alder 18 til 79 · Alle køn · Opdateret 11. sep. 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

RekruttererFase 2
  • Charter Research - Winter Park, Orlando
Alder 18 til 75 · Alle køn · Opdateret 8. sep. 2026 · NCT06143956

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

RekruttererFase 3
  • Kailera Clinical Site, Orlando
  • Kailera Clinical Site, Orlando
Alder 18 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

RekruttererFase 3
  • Clinical Neuroscience Solutions - Orlando, Orlando
  • Combined Research Orlando Phase I IV, Orlando
  • Florida Institute for Clinical Research, Orlando
Alder 18 til 99 · Alle køn · Opdateret 3. sep. 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

RekruttererFase 3
  • Florida Institute for Clinical Research, Orlando
  • Conquest Research - Winter Park, Winter Park · 5 mi væk
Alder 18 til 99 · Alle køn · Opdateret 3. sep. 2026 · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

RekruttererFase 3
  • Clinical Neuroscience Solutions, Orlando
  • Florida Institute for Clinical Research, Orlando
Alder 18 til 99 · Alle køn · Opdateret 27. aug. 2026 · NCT07575399

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

RekruttererFase 3
  • ACCOMPLISH-1 Research Site, Ocoee · 10 mi væk
Alder 18 til 79 · Alle køn · Opdateret 10. aug. 2026 · NCT07654361

Overvægt forsøg i andre byer

Andre studier i Orlando

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.